Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Devchand

Showing results (81-90 of 97) with videos related to

Pageof 10
Sort By:
Breast Cancer Research and Treatment|January 14, 2009
The addition of hormone therapy to tamoxifen does not prevent hot flashes in women at high risk for developing breast cancerCynthia R Osborne, Anita Duncan, Scot Sedlacek, et al.
Plos One|February 25, 2016
Profound Chemopreventative Effects of a Hydrogen Sulfide-Releasing NSAID in the APCMin/+ Mouse Model of Intestinal TumorigenesisMark Paul-Clark, Wagdi Elsheikh, Nicholas Kirkby, et al.
The Oncologist|March 6, 2019
Evaluation of Miracle Mouthwash plus Hydrocortisone Versus Prednisolone Mouth Rinses as Prophylaxis for Everolimus-Associated Stomatitis: A Randomized Phase II StudyVicky E Jones, Kristi J McIntyre, Devchand Paul, et al.
British Journal of Pharmacology|August 11, 2004
Lipoxins and novel 15-epi-lipoxin analogs display potent anti-inflammatory actions after oral administrationGerard Bannenberg, Rose-Laure Moussignac, Karsten Gronert, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 29, 1997
Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gammaS A Kliewer, S S Sundseth, S A Jones, et al.
NPJ Breast Cancer|November 1, 2019
Randomized phase-II evaluation of letrozole plus dasatinib in hormone receptor positive metastatic breast cancer patientsDevchand Paul, Svetislava J Vukelja, Frankie Ann Holmes, et al.
Pharmaceuticals (Basel, Switzerland)|March 20, 2015
A retrospective study of the impact of 21-gene recurrence score assay on treatment choice in node positive micrometastatic breast cancerThomas G Frazier, Kevin R Fox, J Stanley Smith, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2015
Patients with Slowly Proliferative Early Breast Cancer Have Low Five-Year Recurrence Rates in a Phase III Adjuvant Trial of CapecitabineJoyce O'Shaughnessy, Hartmut Koeppen, Yuanyuan Xiao, et al.
Clinical Breast Cancer|July 5, 2011
A randomized phase II study of paclitaxel and bevacizumab with and without gemcitabine as first-line treatment for metastatic breast cancerAdam Brufsky, Karen Hoelzer, Thaddeus Beck, et al.
Clinical Breast Cancer|May 17, 2011
Sunitinib plus paclitaxel versus bevacizumab plus paclitaxel for first-line treatment of patients with advanced breast cancer: a phase III, randomized, open-label trialNicholas J Robert, Mansoor N Saleh, Devchand Paul, et al.
Pageof 10

Showing results (81-90 of 97) with videos related to

Sort By:
Pageof 10
Breast Cancer Research and Treatment|January 14, 2009
The addition of hormone therapy to tamoxifen does not prevent hot flashes in women at high risk for developing breast cancerCynthia R Osborne, Anita Duncan, Scot Sedlacek, et al.
Plos One|February 25, 2016
Profound Chemopreventative Effects of a Hydrogen Sulfide-Releasing NSAID in the APCMin/+ Mouse Model of Intestinal TumorigenesisMark Paul-Clark, Wagdi Elsheikh, Nicholas Kirkby, et al.
The Oncologist|March 6, 2019
Evaluation of Miracle Mouthwash plus Hydrocortisone Versus Prednisolone Mouth Rinses as Prophylaxis for Everolimus-Associated Stomatitis: A Randomized Phase II StudyVicky E Jones, Kristi J McIntyre, Devchand Paul, et al.
British Journal of Pharmacology|August 11, 2004
Lipoxins and novel 15-epi-lipoxin analogs display potent anti-inflammatory actions after oral administrationGerard Bannenberg, Rose-Laure Moussignac, Karsten Gronert, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 29, 1997
Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gammaS A Kliewer, S S Sundseth, S A Jones, et al.
NPJ Breast Cancer|November 1, 2019
Randomized phase-II evaluation of letrozole plus dasatinib in hormone receptor positive metastatic breast cancer patientsDevchand Paul, Svetislava J Vukelja, Frankie Ann Holmes, et al.
Pharmaceuticals (Basel, Switzerland)|March 20, 2015
A retrospective study of the impact of 21-gene recurrence score assay on treatment choice in node positive micrometastatic breast cancerThomas G Frazier, Kevin R Fox, J Stanley Smith, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2015
Patients with Slowly Proliferative Early Breast Cancer Have Low Five-Year Recurrence Rates in a Phase III Adjuvant Trial of CapecitabineJoyce O'Shaughnessy, Hartmut Koeppen, Yuanyuan Xiao, et al.
Clinical Breast Cancer|July 5, 2011
A randomized phase II study of paclitaxel and bevacizumab with and without gemcitabine as first-line treatment for metastatic breast cancerAdam Brufsky, Karen Hoelzer, Thaddeus Beck, et al.
Clinical Breast Cancer|May 17, 2011
Sunitinib plus paclitaxel versus bevacizumab plus paclitaxel for first-line treatment of patients with advanced breast cancer: a phase III, randomized, open-label trialNicholas J Robert, Mansoor N Saleh, Devchand Paul, et al.
Pageof 10